Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | (as per )no data available |
Sector | Biotechnology, HealthcareBiotechnology, Healthcareno data available |
Ticker | ALTno data available |
Financial year endsFY ends | End of Decemberno data available |
Last Closing Price as per Oct 13, 2017, in USD |
2.50n/a |
Market Capitalisation in million USD |
39n/a |
Enterprise Value in million USD |
0n/a |
Common Shares Outstanding as per Jun 30, 2017 |
15,424,891n/a |
Preferred Shares Outstanding as per Jun 30, 2017 |
n/a |
Average Basic Shares Outstanding TTM |
52,276,277n/a |
Average Diluted Shares Outstanding TTM |
52,627,117n/a |
Index Membership |
n/a
|
Revenues | 0n/a |
Gross Profit | 0n/a |
Operating Income | 0n/a |
EBITDA | 0n/a |
Net Profit | 0n/a |
Cash and Cash Equivalents | 0n/a |
Receivables | 0n/a |
Total Current Assets | 0n/a |
PP&E | 0n/a |
Total Assets | 0n/a |
Accounts Payable | 0n/a |
Current Debt | 0n/a |
Total Current Liabilities | 0n/a |
Long-Term Debt | 0n/a |
Total Liabilities | 0n/a |
Total Equity | 0n/a |
Depreciation & Amortisation | 0n/a |
Change in Working Capital | 0n/a |
Operating Cash Flow | 0n/a |
Net Change in PP&E and Intangibles | 0n/a |
Investing Cash Flow | 0n/a |
Dividends Paid | 0n/a |
Financing Cash Flow | 0n/a |
Total Change in Cash | 0n/a |
Free Cash Flow | 0n/a |
Gross Margin | 0.0%n/a |
Operating Margin | 0.0%n/a |
Net Profit Margin | 0.0%n/a |
Return on Equity | 0.0%n/a |
Return on Assets | 0.0%n/a |
Basic EPS | n/a |
Diluted EPS | n/a |
Sales per Share | n/a |
Book Value per Share | n/a |
FCF per Share | n/a |
Dividends per Share | n/a |
Price to Earnings Ratio | n/a |
Price to Sales Ratio | n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | n/a |
EV/Sales | n/a |
Book to Market Value | n/a |
Current Ratio | 0.0%n/a |
Liabilities to Equity Ratio | 0.0%n/a |
Debt to Assets Ratio | 0.0%n/a |
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|---|
|
21
|
24
|
25
|
18
|
10
|
11
|
5
|
|
21
|
21
|
20
|
15
|
9
|
5
|
5
|
|
18
|
14
|
12
|
13
|
11
|
6
|
12
|
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
45
|
36
|
31
|
29
|
20
|
14
|
16
|
|
-24
|
-12
|
-6
|
-11
|
-10
|
-3
|
-11
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
-6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
-5
|
7
|
1
|
0
|
1
|
0
|
-1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
217
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-11
|
8
|
2
|
-1
|
0
|
0
|
216
|
|
-35
|
-4
|
-5
|
-12
|
-10
|
-3
|
205
|
|
0
|
0
|
0
|
0
|
0
|
0
|
-11
|
|
-35
|
-4
|
-5
|
-12
|
-10
|
-3
|
194
|
Remarks |
restated on Mar 14, 2013
n/a
calculated values,
|
restated on Mar 11, 2014
n/a
calculated values,
|
restated on Mar 11, 2015
n/a
calculated values,
|
restated on Mar 11, 2016
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|---|
Assets | |||||||
|
12
|
11
|
13
|
10
|
19
|
16
|
3
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
5
|
4
|
2
|
1
|
0
|
1
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
4
|
3
|
4
|
2
|
0
|
1
|
0
|
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
24
|
20
|
20
|
14
|
19
|
17
|
4
|
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
2
|
2
|
2
|
2
|
2
|
2
|
19
|
|
27
|
23
|
23
|
17
|
22
|
20
|
38
|
Liabilities and owners' equity | |||||||
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
458629
|
|
3
3128203
|
1
1445700
|
2
1697280
|
1
1128172
|
0
391396
|
1
521122
|
2
2005208
|
|
3
3035284
|
3
2655330
|
2
2328877
|
3
3182687
|
1
1195412
|
1
1248708
|
3
2972745
|
|
0
0
|
1
514312
|
1
1381755
|
0
341723
|
0
0
|
0
0
|
0
19753
|
|
0
0
|
0
0
|
0
0
|
0
51663
|
0
0
|
0
0
|
0
14388
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
1
749997
|
1
999996
|
1
746146
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
1
1330507
|
1
1091740
|
0
0
|
0
0
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
178509
|
0
16411
|
0
0
|
|
6
6163487
|
5
4615342
|
7
7488416
|
7
6795981
|
3
2581789
|
2
2179441
|
5
5470723
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
1001
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
1
525950
|
|
0
0
|
0
0
|
2
1704108
|
1
730279
|
0
0
|
0
0
|
0
179424
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
70326
|
0
11250
|
0
0
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
108641
|
0
0
|
|
0
461858
|
0
449709
|
1
579427
|
1
588745
|
0
493137
|
0
433407
|
0
15914
|
|
8
8362995
|
2
1886652
|
1
1295613
|
2
1688572
|
1
629170
|
0
491791
|
0
0
|
|
15
14988340
|
7
6951703
|
11
11067564
|
10
9803577
|
4
3704096
|
3
3213280
|
6
6193012
|
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
0
0
|
|
0
4624
|
0
4824
|
0
4835
|
0
5230
|
0
6360
|
0
6438
|
0
692
|
|
201
200847468
|
209
208525917
|
210
210495905
|
218
217877117
|
239
238780633
|
240
240366704
|
71
71034899
|
|
1
1250497
|
1
1010522
|
0
-217328
|
0
-218710
|
0
-229528
|
0
0
|
-8
-7574812
|
|
-190
-189891884
|
-194
-193689457
|
-199
-198609572
|
-210
-210327925
|
-220
-220283320
|
-224
-223724025
|
-31
-31259449
|
|
12
12210705
|
16
15851806
|
12
11673840
|
7
7335712
|
18
18274145
|
17
16649117
|
32
32207323
|
|
27
27199045
|
23
22803509
|
23
22741404
|
17
17139289
|
22
21978241
|
20
19862397
|
38
38400335
|
Remarks | restated on Mar 8, 2012 n/a | restated on Mar 14, 2013 n/a | restated on Mar 11, 2014 n/a | restated on Mar 11, 2015 n/a | restated on Mar 11, 2016 n/a | restated on Mar 14, 2017 n/a | restated on Aug 14, 2017 n/a |
in million USD | FY '10 | FY '11 | FY '12 | FY '13 | FY '14 | FY '15 | FY '16 |
---|---|---|---|---|---|---|---|
|
-35
|
-4
|
-5
|
-12
|
-10
|
-3
|
194
|
|
0
|
0
|
-1
|
0
|
0
|
0
|
0
|
|
3
|
3
|
2
|
1
|
2
|
1
|
2
|
|
5
|
-7
|
-1
|
0
|
-1
|
0
|
1
|
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
-1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
0
|
2
|
1
|
1
|
0
|
0
|
|
5
|
1
|
-1
|
2
|
2
|
-1
|
0
|
|
-1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
1
|
-2
|
0
|
-1
|
-1
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
-9
|
0
|
0
|
1
|
-2
|
0
|
1
|
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
0
|
1
|
1
|
-1
|
0
|
0
|
0
|
|
-15
|
-8
|
-2
|
-7
|
-8
|
-3
|
202
|
|
0
|
0
|
0
|
0
|
0
|
0
|
-67
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
2
|
0
|
0
|
0
|
0
|
-67
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
22
|
6
|
0
|
6
|
18
|
1
|
4
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
0
|
0
|
3
|
-1
|
-1
|
-1
|
0
|
|
0
|
0
|
1
|
0
|
-1
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
21
|
6
|
4
|
5
|
17
|
0
|
4
|
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
9
|
-1
|
1
|
-2
|
8
|
-3
|
138
|
Remarks |
restated on Mar 14, 2013
n/a
calculated values,
|
restated on Mar 11, 2014
n/a
calculated values,
|
restated on Mar 11, 2015
n/a
calculated values,
|
restated on Mar 11, 2016
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|
restated on Mar 14, 2017
n/a
calculated values,
|